A 3D View of Genomics, Targeted Therapeutic Options, and Treatment Sequencing for the Management of Hematologic Malignancies – Amarillo, TX
This activity will cover the treatment and management of patients with AML and CLL.
This activity will cover the treatment and management of patients with AML and CLL.
This live activity will cover treating and managing patients with sleep-related disorders.
This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
This live activity will cover treating and managing atopic dermatitis in pediatric and adolescent patients.
This live activity will cover treating and managing atopic dermatitis in pediatric and adolescent patients.
This activity will cover the treatment and management of patients with type 2 diabetes mellitus (T2DM).
This live activity will cover treating and managing atopic dermatitis in pediatric and adolescent patients.
This activity will cover the treatment and management of patients with type 2 diabetes mellitus (T2DM).
This activity will cover the treatment and management of patients with type 2 diabetes mellitus (T2DM).
This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
This live activity will cover treating and managing patients with sleep-related disorders.
This activity will cover the treatment and management of patients with type 2 diabetes mellitus (T2DM).